RxDoctor Payments Data

Sheridan Brown

Physician Assistant · Columbia, MONPI 1770055741

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 355 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 27.8% of the total. Reporting peaked in 2024 at $2,110 and has fallen 51.7% since, to $1,018 in 2025. Among physician assistant clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,926in general payments, 2019–2025

Across 355 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$1K
  • Johnson & Johnson$1K
  • Lilly USA, LLC$570
  • E.r. Squibb & Sons, L.L.C.$545
  • UCB, Inc.$208
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$6,70597%
  • Education$2213%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,926 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
TremfyaGuselkumab16$221,715
Cosentyx Unoready PenSecukinumab15$137,697
Clobetasol Propionate49$1,801
Triamcinolone Acetonide96$1,012
Ketoconazole41$812
Fluocinonide19$723
Doxycycline Hyclate23$553
Clindamycin Phosphate12$444
Cephalexin18$369
Nystatin14$233
Mupirocin25$176
Hydrocortisone27$111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonTremfya$1,152$221,71516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →